Silver Grove Financial Group, Inc.
Source: SEC Form 13F · as of Mar 2026Silver Grove Financial Group, Inc. holds 23 biotech & pharma companies tracked by BioSniper, totaling $2.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
23
Total value held
$2.4M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 1,006 | $926K |
| JNJJOHNSON & JOHNSON | 1,964 | $480K |
| ABBVAbbVie Inc. | 1,969 | $428K |
| PMPhilip Morris International Inc | 1,726 | $285K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 389 | $105K |
| ZTSZoetis Inc. | 766 | $91K |
| GMOptec International, Inc. | 809 | $60K |
| IDXXIDEXX LABORATORIES INC /DE | 22 | $12K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 205 | $11K |
| BMYBRISTOL MYERS SQUIBB CO | 114 | $7K |
| PMVPPMV Pharmaceuticals, Inc. | 5,082 | $6K |
| AMGNAMGEN INC | 13 | $5K |
| GILDGILEAD SCIENCES, INC. | 28 | $4K |
| IQVIQVIA Holdings Inc. | 17 | $3K |
| ELVElevance Health Inc. | 7 | $2K |
| ARMPArmata Pharmaceuticals, Inc. | 200 | $2K |
| ABTABBOTT LABORATORIES | 19 | $2K |
| CORCencora Inc. | 4 | $1K |
| MRKMerck & Co., Inc. | 9 | $1K |
| ARRYARRAY BIOPHARMA INC | 125 | $904 |
| BTAIBioXcel Therapeutics, Inc. | 334 | $447 |
| AVTXAvalo Therapeutics, Inc. | 1 | $15 |
| INOINOVIO PHARMACEUTICALS, INC. | 5 | $9 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.